Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
PetMed Express, Inc. stock logo
PETS
PetMed Express
$1.82
+0.8%
$2.16
$1.57
$4.10
$38.79M0.77136,457 shs13,079 shs
111, Inc. Sponsored ADR stock logo
YI
111
$4.48
+0.6%
$5.84
$2.48
$11.17
$39.32M0.633,714 shs1,693 shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
PetMed Express, Inc. stock logo
PETS
PetMed Express
-1.64%+5.26%-19.28%-27.71%-50.00%
111, Inc. Sponsored ADR stock logo
YI
111
-2.63%+1.14%-23.14%-32.58%-45.20%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
PetMed Express, Inc. stock logo
PETS
PetMed Express
$1.82
+0.8%
$2.16
$1.57
$4.10
$38.79M0.77136,457 shs13,079 shs
111, Inc. Sponsored ADR stock logo
YI
111
$4.48
+0.6%
$5.84
$2.48
$11.17
$39.32M0.633,714 shs1,693 shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
PetMed Express, Inc. stock logo
PETS
PetMed Express
-1.64%+5.26%-19.28%-27.71%-50.00%
111, Inc. Sponsored ADR stock logo
YI
111
-2.63%+1.14%-23.14%-32.58%-45.20%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
PetMed Express, Inc. stock logo
PETS
PetMed Express
1.50
ReduceN/AN/A
111, Inc. Sponsored ADR stock logo
YI
111
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest PETS and YI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/11/2026
PetMed Express, Inc. stock logo
PETS
PetMed Express
DowngradeSell (D-)Sell (E+)
6/4/2026
111, Inc. Sponsored ADR stock logo
YI
111
DowngradeSell (D-)Sell (E+)
5/21/2026
111, Inc. Sponsored ADR stock logo
YI
111
UpgradeSell (E+)Sell (D-)
5/12/2026
PetMed Express, Inc. stock logo
PETS
PetMed Express
Reiterated RatingSell (D-)
5/7/2026
111, Inc. Sponsored ADR stock logo
YI
111
DowngradeSell (D-)Sell (E+)
4/30/2026
PetMed Express, Inc. stock logo
PETS
PetMed Express
UpgradeHold
4/22/2026
111, Inc. Sponsored ADR stock logo
YI
111
UpgradeSell (E+)Sell (D-)
(Data available from 6/17/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
PetMed Express, Inc. stock logo
PETS
PetMed Express
$179.02M0.21$0.30 per share5.92$1.35 per share1.33
111, Inc. Sponsored ADR stock logo
YI
111
$11.39B0.00N/AN/A($11.74) per share-0.39
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
PetMed Express, Inc. stock logo
PETS
PetMed Express
-$57.29M-$2.75N/A19.94N/A-32.00%-76.86%-31.67%7/27/2026 (Estimated)
111, Inc. Sponsored ADR stock logo
YI
111
-$9.65M-$1.40N/AN/AN/A-0.76%N/A-3.80%8/20/2026 (Estimated)

Latest PETS and YI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
6/2/2026Q4 2026
PetMed Express, Inc. stock logo
PETS
PetMed Express
-$0.18-$0.19-$0.01-$0.19$52.00 million$42.82 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
PetMed Express, Inc. stock logo
PETS
PetMed Express
N/AN/A-100.00%N/AN/A
111, Inc. Sponsored ADR stock logo
YI
111
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
PetMed Express, Inc. stock logo
PETS
PetMed Express
N/A
0.84
0.58
111, Inc. Sponsored ADR stock logo
YI
111
N/A
1.08
0.49

Institutional Ownership

CompanyInstitutional Ownership
PetMed Express, Inc. stock logo
PETS
PetMed Express
73.33%
111, Inc. Sponsored ADR stock logo
YI
111
21.32%

Insider Ownership

CompanyInsider Ownership
PetMed Express, Inc. stock logo
PETS
PetMed Express
2.00%
111, Inc. Sponsored ADR stock logo
YI
111
43.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
PetMed Express, Inc. stock logo
PETS
PetMed Express
21021.37 million20.94 millionOptionable
111, Inc. Sponsored ADR stock logo
YI
111
1,0638.79 million4.93 millionOptionable

Recent News About These Companies

Yang Luke Chen Sells 44,000 Shares of 111 (NASDAQ:YI) Stock
111, Inc. Sponsored ADR
111: Q1 Earnings Snapshot
111: Q4 Earnings Snapshot
111: Q3 Earnings Snapshot
111: Q2 Earnings Snapshot
111 Inc Share Price | NASDAQ: YI Stock - Investing.com UK

Media Sentiment Over Time

PetMed Express stock logo

PetMed Express NASDAQ:PETS

$1.82 +0.02 (+0.83%)
As of 01:25 PM Eastern
This is a fair market value price provided by Massive. Learn more.

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.

111 stock logo

111 NASDAQ:YI

$4.48 +0.03 (+0.58%)
As of 01:01 PM Eastern
This is a fair market value price provided by Massive. Learn more.

111, Inc. engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies. The B2B segment includes the sale of pharmaceutical products to pharmacy customers through 1 Drug Mall. The company was founded by Gang Yu and Jun Ling Liu in May 2013 and is headquartered in Shanghai, China.